Compliance Investigations & White Collar


Rivkin Radler Attorneys Named 2020 New Jersey Super Lawyers
March 13, 2020 | Privacy, Data & Cyber Law | Trusts & Estates | Compliance Investigations & White Collar | Commercial Litigation | Insurance Fraud | Intellectual Property
HACKENSACK, NJ  – – Rivkin Radler LLP is pleased to announce that Nancy A. Del Pizzo, Jenna Gabay and Gene Kang, have been named 2020 New Jersey Super Lawyers.  Del Pizzo was named a Top Rated Intellectual Property Litigation Attorney; and Gabay and Kang were named Rising Stars. A partner in the firm’s Commercial Litigation; …
Read More
Malerba, Kaiser to Speak on ACFE Healthcare Fraud Panel
February 26, 2020 | Compliance Investigations & White Collar | Health Services
On Thursday, May 7, 2020, Benjamin Malerba and Jeff Kaiser will participate in a panel discussion sponsored by the Long Island Chapter of the Association of Certified Fraud Examiners. The program, to be held at the Westbury Manor, will feature a panel of experts discussing the detection and prosecution of healthcare fraud. For details and …
Read More
Ullman Quoted on ABH Manufacturing Recall
February 3, 2020 | Compliance Investigations & White Collar
Marc Ullman was interviewed for an article in Natural Products Insider entitled “Supplement contract manufacturing recall ‘unprecedented.'” The article discusses how ABH, along with 859 of its nutritional products brands, was shut down by a U.S. Department of Justice consent decree. To read the article, click here. …
Read More
Shapiro Speaks to NYSBA Food, Drug and Cosmetic Law Section
January 29, 2020 | Compliance Investigations & White Collar
On Thursday, January 30, 2020, Steven Shapiro will present to the New York State Bar Association’s Food, Drug and Cosmetic Law Section as part of its Off-Label Promotion Update. His presentation is entitled “Promotion of CBD following Epidiolex for Rx, OTC drugs and other products. For information and to register, click here. …
Read More
Ullman’s Op-Ed on CBD Appears in Long Island Business News
| Compliance Investigations & White Collar
On January 29, 2020, Marc Ullman’s opinion piece, “FDA’s lack of CBD guidance is a disservice to Long Island firms,” appeared in Long Island Business News. Marc notes that an exploding market for CBD products has created a conundrum for companies wishing to cash in. Either they obey FDA’s regulations and lose out, or they break …
Read More
Ullman Quoted on Contract Manufacturer Product Recall
January 22, 2020 | Compliance Investigations & White Collar
Marc Ullman spoke with Nutraingredients-USA about a recall of 1,200 products manufactured by Edgewood, NY-based ABH Nature’s Products, Inc. (also doing business as ABH Pharma, Inc. and Stocknutra.com, Inc.). The company issued a recall under a consent decree with the United States District Court for the Eastern District of New York. The recall is intended to …
Read More
Ullman Quoted on Proposed CBD Legislation
January 21, 2020 | Compliance Investigations & White Collar
Marc Ullman spoke to Nutraingredients-USA about a new bill that would include CBD in the definition of dietary supplements in the federal Food, Drug and Cosmetic Act. The legislation is an attempt to cope with the raft of products now on the market that are technically illegal. Marc said he thinks the bill will only …
Read More
Ullman Quoted on FDA’s Targeting of CBD
January 17, 2020 | Compliance Investigations & White Collar
Marc Ullman was quoted in a Nutraingredients-USA story entitled “Warning letter analysis shows FDA has target on CBD, not hemp.” To read the article, click here. …
Read More
Shapiro Speaks on Nutritional Ingredient Expert Panel
January 13, 2020 | Compliance Investigations & White Collar
Steven Shapiro participated in Nutrition Industry Executive’s Industry Forecast. The article discussed the biggest issues facing the nutritional supplement industry in 2020. To read the article, click here. …
Read More
Ullman Speaks to Natural Products Insider about Listing Supplements with the FDA
January 7, 2020 | Compliance Investigations & White Collar
Marc Ullman was quoted in a Natural Products Insider article entitled “Trade group plans to lobby Congress on listing dietary supplement products  with FDA.” The story reveals that the Council for Responsible Nutrition will look for sponsors of a bill to require nutritional supplements to be listed with the Food and Drug Administration. Marc, who opposes …
Read More
Next Page

Get legal updates and news delivered to your inbox